These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3134495)

  • 21. Investigation by syringe method of effect of tampons on production in vitro of toxic shock syndrome toxin 1 by Staphylococcus aureus.
    Lee AC; Crass BA; Bergdoll MS
    J Clin Microbiol; 1987 Jan; 25(1):87-90. PubMed ID: 3793877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of air in growth and production of toxic shock syndrome toxin 1 by Staphylococcus aureus in experimental cotton and rayon tampons.
    Fischetti VA; Chapman F; Kakani R; James J; Grun E; Zabriskie JB
    Rev Infect Dis; 1989; 11 Suppl 1():S176-81. PubMed ID: 2928634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of blood and different media on the production of toxic shock syndrome toxin 1 by Staphylococcus aureus in the tampon sac method.
    Reiser RF; Denzin LK; Bergdoll MS
    J Clin Microbiol; 1988 Dec; 26(12):2672-4. PubMed ID: 3068256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of cotton and cotton/rayon tampons for effect on production of toxic shock syndrome toxin.
    Schlievert PM
    J Infect Dis; 1995 Oct; 172(4):1112-4. PubMed ID: 7561191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of magnesium ion in the pathogenesis of toxic shock syndrome.
    Kass EH; Parsonnet J; Mills JT
    Trans Assoc Am Physicians; 1987; 100():158-63. PubMed ID: 3137706
    [No Abstract]   [Full Text] [Related]  

  • 26. Influence of focal growth conditions on the pathogenesis of toxic shock syndrome.
    Todd JK; Todd BH; Franco-Buff A; Smith CM; Lawellin DW
    J Infect Dis; 1987 Apr; 155(4):673-81. PubMed ID: 3546518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toxic shock syndrome toxin-1 (TSST-1): influence of its production by subinhibitory antibiotic concentrations.
    Dickgiesser N; Wallach U
    Infection; 1987; 15(5):351-3. PubMed ID: 3692606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Staphylococcus aureus toxic shock syndrome toxin-1 (TSST-1) production and Lactobacillus species growth in a defined medium simulating vaginal secretions.
    Stingley RL; Liu H; Mullis LB; Elkins CA; Hart ME
    J Microbiol Methods; 2014 Nov; 106():57-66. PubMed ID: 25135489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of tampon wraps on production of toxic shock syndrome toxin 1.
    Robbins RN; Kelly BJ; Hehl GL; Bergdoll MS
    Rev Infect Dis; 1989; 11 Suppl 1():S197-202. PubMed ID: 2928637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The toxic shock syndrome revisited.
    Kass EH
    Postgrad Med J; 1985; 61 Suppl 1():45-8. PubMed ID: 4059159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amino acid requirements for the growth and production of some exocellular products of Staphylococcus aureus.
    Taylor D; Holland KT
    J Appl Bacteriol; 1989 Apr; 66(4):319-29. PubMed ID: 2753836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth of Staphylococcus aureus and synthesis of toxic shock syndrome toxin 1 in different in vitro systems.
    Kirkland JJ; Ryan CA; Kohrman KA; Danneman PJ
    Rev Infect Dis; 1989; 11 Suppl 1():S188-95; discussion S195-6. PubMed ID: 2928636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation by improved syringe method of effect of tampons on production in vitro of toxic shock syndrome toxin 1 by Staphylococcus aureus.
    Wong AC; Downs SA
    J Clin Microbiol; 1989 Nov; 27(11):2482-7. PubMed ID: 2808672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation and control of toxic shock syndrome toxin 1: overview.
    Bergdoll MS
    Rev Infect Dis; 1989; 11 Suppl 1():S142-4. PubMed ID: 2648538
    [No Abstract]   [Full Text] [Related]  

  • 35. Combination of flucloxacillin and gentamicin inhibits toxic shock syndrome toxin 1 production by Staphylococcus aureus in both logarithmic and stationary phases of growth.
    van Langevelde P; van Dissel JT; Meurs CJ; Renz J; Groeneveld PH
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1682-5. PubMed ID: 9257741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxygen and carbon dioxide regulation of toxic shock syndrome toxin 1 production by Staphylococcus aureus MN8.
    Yarwood JM; Schlievert PM
    J Clin Microbiol; 2000 May; 38(5):1797-803. PubMed ID: 10790102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Staphylococcus aureus isolates from patients with nonmenstrual toxic shock syndrome. Evidence for additional toxins.
    Garbe PL; Arko RJ; Reingold AL; Graves LM; Hayes PS; Hightower AW; Chandler FW; Broome CV
    JAMA; 1985 May; 253(17):2538-42. PubMed ID: 3981783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contribution of toxic shock syndrome toxin-1 to systemic inflammation investigated by a mouse model of cervicovaginal infection with Staphylococcus aureus.
    Asano K; Narita K; Hirose S; Nakane A
    Med Microbiol Immunol; 2018 Nov; 207(5-6):297-306. PubMed ID: 29980843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Production of toxic shock syndrome toxin-1 (TSST-1) by Staphylococcus aureus strains isolated from humans, animals and foods in Nigeria.
    Adesiyun AA; Lenz W; Schaal KP
    Microbiologica; 1992 Apr; 15(2):125-33. PubMed ID: 1602983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Co-production of staphylococcal enterotoxin A with toxic shock syndrome toxin-1 (TSST-1) enhances TSST-1 mediated mortality in a D-galactosamine sensitized mouse model of lethal shock.
    De Boer ML; Kum WW; Pang LT; Chow AW
    Microb Pathog; 1999 Aug; 27(2):61-70. PubMed ID: 10458917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.